Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 47 of 47 from CROI 2022
WELCOME AND DAILY ROADMAP
Elaine J Abrams
Columbia University, New York, NY, USA
from CROI 2022 on February 16, 2022 8:30 AM-9:30 AM
NEW ANTIRETROVIRALS AND THE FUTURE OF HIV TREATMENT AND PREVENTION   (ABSTRACT 116)
Chloe L Orkin
Queen Mary University of London, London, United Kingdom
from CROI 2022 on February 16, 2022 8:30 AM-9:30 AM
PAST AND FUTURE OF HIV VACCINES   (ABSTRACT 117)
Mark Feinberg
IAVI, New York, NY, USA
from CROI 2022 on February 16, 2022 8:30 AM-9:30 AM
INTRODUCTION OF SPEAKERS PART I
Serena S Spudich
Yale University, New Haven, CT, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
HIV-1 RNA TRANSCRIPTS IN CSF CD4+ T CELLS, NOT MONOCYTES, ARE LINKED TO BRAIN INJURY   (ABSTRACT 126)
John Zaunders
St Vincent's Hospital, Sydney, NSW, Australia
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
PBR28 PET IMAGING IN PEOPLE WHO STARTED ART DURING ACUTE VERSUS CHRONIC HIV INFECTION   (ABSTRACT 127)
Jasmini Alagaratnam
Imperial College London, London, Greater London, United Kingdom
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LONGITUDINAL MODELING OF EARLY HIV BURDEN IN THE CENTRAL NERVOUS SYSTEM   (ABSTRACT 128)
Victor Diego Armengol
Yale School of Medicine, New Haven, CT, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
CD4+ DEPLETION RESULTS IN ROBUST CNS REBOUND AND LARGER MACROPHAGE RESERVOIRS   (ABSTRACT 129)
Rebecca T Veenhuis
Johns Hopkins Univeristy, Baltimore, MD, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Jasmini Alagaratnam
Imperial College London, London, Greater London, United Kingdom
Serena S Spudich
Yale University, New Haven, CT, USA
Victor Diego Armengol
Yale School of Medicine, New Haven, CT, USA
Rebecca T Veenhuis
Johns Hopkins Univeristy, Baltimore, MD, USA
John Zaunders
St Vincent's Hospital, Sydney, NSW, Australia
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
NEUROSYMPTOMATIC HIV-1 CSF ESCAPE ASSOCIATES WITH REPLICATION IN CNS CD4+ T CELLS   (ABSTRACT 130)
Laura Kincer
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
SARS-COV-2 CSF N-ANTIGEN DETECTION IS ASSOCIATED WITH CNS INFLAMMATION IN NEUROCOVID   (ABSTRACT 131)
Arvid Eden
Institute of Biomedicine, Gothenburg, Sweden
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
IS THERE A ROLE OF NOVEL ART REGIMENS IN THE DECLINING PREVALENCE OF HAND?   (ABSTRACT 132)
Ilaria Mastrorosa
Istituto Nazionale Malattie Infettive L Spallanzani, Rome, Italy
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
ACTG A5324: A RANDOMIZED TRIAL OF ART INTENSIFICATION FOR COGNITIVE IMPAIRMENT IN PWH   (ABSTRACT 133)
Scott L Letendre
University of California San Diego, San Diego, CA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Arvid Eden
Institute of Biomedicine, Gothenburg, Sweden
Dennis L Kolson
University of Pennsylvania, Philadelphia, PA, USA
Laura Kincer
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Scott L Letendre
University of California San Diego, San Diego, CA, USA
Ilaria Mastrorosa
Istituto Nazionale Malattie Infettive L Spallanzani, Rome, Italy
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
IMPROVING INTESTINAL BARRIER USING GLP-2 AGONIST REDUCES ARTERIAL INFLAMMATION IN PWH   (ABSTRACT 134)
Janet Lo
Massachusetts General Hospital, Boston, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
DOLUTEGRAVIR WITH RECYCLED NRTIS IS NONINFERIOR TO PI-BASED ART: VISEND TRIAL   (ABSTRACT 135)
Lloyd B Mulenga
University Teaching Hospital, Lusaka, Zambia
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
A RANDOMIZED TRIAL OF SWITCHING TREATMENT-EXPERIENCED ADULTS FROM PI/R TO DTG   (ABSTRACT 136)
Loice A Ombajo
University of Nairobi, Nairobi, Kenya
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
NUCLEOSIDES AND DARUNAVIR/DOLUTEGRAVIR IN AFRICA (NADIA) TRIAL: OUTCOMES AT 96 WEEKS   (ABSTRACT 137)
Nicholas Paton
National University of Singapore, Singapore, Singapore
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Janet Lo
Massachusetts General Hospital, Boston, MA, USA
Joseph J Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Lloyd B Mulenga
University Teaching Hospital, Lusaka, Zambia
Loice A Ombajo
University of Nairobi, Nairobi, Kenya
Nicholas Paton
National University of Singapore, Singapore, Singapore
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LENACAPAVIR AS PART OF A COMBINATION REGIMEN IN TREATMENT NAIVE PWH: WEEK 54 RESULTS   (ABSTRACT 138)
Samir Gupta
Indiana University School of Medicine, Indianapolis, IN, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
VIRAL ESCAPE DURING TRIPLE BROADLY NEUTRALIZING ANTIBODY THERAPY AGAINST HIV-1   (ABSTRACT 139)
Boris Juelg
Massachusetts General Hospital, Cambridge, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
PHASE I STUDY OF LONG-ACTING 3BNC117 AND 10-1074 IN VIREMIC ADULTS LIVING WITH HIV   (ABSTRACT 140)
Marina Caskey
The Rockefeller University, New York, NY, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Marina Caskey
The Rockefeller University, New York, NY, USA
Angela Kashuba
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Samir Gupta
Indiana University School of Medicine, Indianapolis, IN, USA
Boris Juelg
Massachusetts General Hospital, Cambridge, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
INTRODUCTION OF SPEAKERS PART I
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
INFLAMMASOMES AND IL-1Β: AN INNATE IMMUNE AXIS IN CD4+ T CELLS DRIVING HIV INFECTION   (ABSTRACT 118)
Jeffrey Alan Tomalka
Emory University, Atlanta, GA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
RAPID LOSS OF CD4+ T CELLS BY PYROPTOSIS IN ACUTELY SIV-INFECTED RHESUS MACAQUES   (ABSTRACT 119)
Xuan He
Beth Israel Deaconess Medical Center, Boston, MA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
EXPERIMENTAL MICROBIAL DYSBIOSIS ENHANCES RECTAL SIV ACQUISITION IN RHESUS MACAQUES   (ABSTRACT 120)
Alexandra Ortiz
National Institutes of Health, Bethesda, MD, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
PHASE IIB EFFICACY TRIAL OF MOSAIC HIV-1 VACCINE REGIMEN IN AFRICAN WOMEN: IMBOKODO   (ABSTRACT 121)
Glenda E Gray
South African Medical Research Council, Cape Town, South Africa
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Glenda E Gray
South African Medical Research Council, Cape Town, South Africa
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Xuan He
Beth Israel Deaconess Medical Center, Boston, MA, USA
Alexandra Ortiz
National Institutes of Health, Bethesda, MD, USA
Jeffrey Alan Tomalka
Emory University, Atlanta, GA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
ADMINISTRATION OF 3BNC117 AT ART INITIATION INDUCES LONG-TERM HIV CD8 T-CELL IMMUNITY   (ABSTRACT 122)
Míriam Rosás-Umbert
Aarhus University Hospital, Aarhus, Denmark
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
CD8+ LYMPHOCYTES MODULATE STEMNESS AND SURVIVAL PATHWAYS IN HIV-INFECTED CD4+ T CELLS   (ABSTRACT 123)
Deanna Kulpa
Emory University, Atlanta, GA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
HIGH NEUTRALIZING CONVALESCENT PLASMA RESULTS IN RAPID CLEARANCE OF SARS-COV-2   (ABSTRACT 124)
Irene A Abela
University of Zurich, Zürich, Switzerland
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
SARS-COV-2 ANTIBODY RESPONSES IN INDIVIDUALS FOLLOWING MRNA BOOSTER VACCINATION   (ABSTRACT 125)
Frauke Muecksch
The Rockefeller University, New York, NY, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Irene A Abela
University of Zurich, Zürich, Switzerland
Guido Silvestri
Emory University, Atlanta, GA, USA
Lavinia Franchitti
Emory University, Atlanta, GA, USA
Frauke Muecksch
The Rockefeller University, New York, NY, USA
Míriam Rosás-Umbert
Aarhus University Hospital, Aarhus, Denmark
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
PREVALENCE OF SYPHILIS AND HIV/SYPHILIS COINFECTION IN 5 SUB-SAHARAN COUNTRIES   (ABSTRACT 141)
Rose Killian
Columbia University, Dania, FL, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
CHANGES IN HIV AND STI TESTING AND DIAGNOSES DURING THE COVID-19 PANDEMIC   (ABSTRACT 142)
Jennifer J Chang
Southern California Permanente Medical Group, Los Angeles, CA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
CDC’S DIRECT-TO-CONSUMER DISTRIBUTION OF 100,000 HIV SELF-TESTS   (ABSTRACT 143)
Pollyanna R Chavez
Centers for Disease Control and Prevention, Atlanta, GA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
HIV SELF-TESTING UNCOVERS HIGH BURDEN OF HIDDEN INFECTIONS IN INDIA   (ABSTRACT 144)
Jalpa H Thakker
Johns Hopkins University School of Medicine, New Delhi, India
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART I
Jennifer J Chang
Southern California Permanente Medical Group, Los Angeles, CA, USA
Connie L Celum
University of Washington, Seattle, WA, USA
Pollyanna R Chavez
Centers for Disease Control and Prevention, Atlanta, GA, USA
Rose Killian
Columbia University, Dania, FL, USA
Jalpa H Thakker
Johns Hopkins University School of Medicine, New Delhi, India
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
HIGH HIV SELF-TESTING OF MALE PARTNERS OF WOMEN LIVING WITH HIV IN RURAL SOUTH AFRICA   (ABSTRACT 145)
Dvora Joseph Davey
University of California Los Angeles, Los Angeles, CA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
SIX-MONTH PREP WITH HIV SELF-TESTING TO IMPROVE DELIVERY KENYA: A RANDOMIZED TRIAL   (ABSTRACT 146)
Kenneth Ngure
Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya, Kenya
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
SUCCESS OF ASSISTED PARTNER NOTIFICATION AMONG PATIENTS WITH PRIOR HIV DIAGNOSES   (ABSTRACT 147)
Harugumi Chirairo
International Training and Education Center for Health, Windhoek, Namibia
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LOW RISK OF ADVERSE EVENTS FOLLOWING ASSISTED PARTNER NOTIFICATION IN MOZAMBIQUE   (ABSTRACT 148)
Matthew R Golden
University of Washington, Seattle, WA, USA
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
LIVE QUESTIONS AND ANSWERS PART II
Harugumi Chirairo
International Training and Education Center for Health, Windhoek, Namibia
Andrew N Phillips
University College London, London, United Kingdom
Matthew R Golden
University of Washington, Seattle, WA, USA
Dvora Joseph Davey
University of California Los Angeles, Los Angeles, CA, USA
Kenneth Ngure
Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya, Kenya
from CROI 2022 on February 16, 2022 9:45 AM-11:45 AM
SESSION OVERVIEW
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
SESSION OVERVIEW
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
NEW AND IMPROVED T CELL CARS FOR HIV ERADICATION OR CONTROL
James L Riley
University of Pennsylvania, Philadelphia, PA, USA
GENERATING CAR T CELLS IN VIVO
Hans-Peter Kiem
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
NATURAL KILLER CELL CARS: NEW APPROACHES TO CURE LEUKEMIA AND LYMPHOMA
Katy Rezvani
MD Anderson Cancer Center, Houston, TX, USA
STIMULATING CARS WITH MRNA VACCINES
Benjamin Rengstl
BioNTech SE, Mainz, Germany
PANEL DISCUSSION
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
PANEL DISCUSSION
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2022 on February 16, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
INTRODUCTION OF EXPERT PANELISTS
Joseph J Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
INTRODUCTION OF EXPERT PANELISTS
Natella Rakhmanina
Children's National Hospital, Washington, DC, USA
INTRODUCTION OF EXPERT PANELISTS
Hermione Lyall
Imperial College Healthcare NHS Trust, London, United Kingdom
INTRODUCTION OF EXPERT PANELISTS
Mina C Hosseinipour
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
INTRODUCTION OF EXPERT PANELISTS
Annemarie Wensing
University Medical Center Utrecht, Utrecht, Netherlands
INTRODUCTION OF EXPERT PANELISTS
Timothy Wilkin
Weill Cornell Medicine, New York, NY, USA
IS 'OUCH' THE ANSWER? - CASE PRESENTATION AND DISCUSSION
Mina C Hosseinipour
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
NINJA MUTANT DECADES? - CASE PRESENTATION AND DISCUSSION
Natella Rakhmanina
Children's National Hospital, Washington, DC, USA
TOO MANY, TOO LONG? - CASE PRESENTATION AND DISCUSSION
Timothy Wilkin
Weill Cornell Medicine, New York, NY, USA
SESSION WRAP-UP
from CROI 2022 on February 16, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
SESSION OVERVIEW
Jean-Michel Molina
University of Paris, Paris, France
ROLE OF VARIANTS AND VIRAL LOAD IN SARS-COV2 TRANSMISSION
Arnaud Fontanet
Institut Pasteur, Paris, France
IS SARS-COV-2 VIRAL LOAD ASSOCIATED WITH DISEASE PROGRESSION AND RESPONSE TO TREATMENT?
Matthew A Spinelli
University of California San Francisco, San Francisco, CA, USA
ARE NEW SARS COV-2 VARIANTS ASSOCIATED WITH MORE SEVERE DISEASE?
Fiona P. Havers
Centers for Disease Control and Prevention, Atlanta, GA, USA
VIRAL LOAD KINETICS IN PARTIALLY OR FULLY VACCINATED INDIVIDUALS INFECTED WITH SARS COV-2
Annelies Wilder-Smith
London School of Hygiene and Tropical Medicine, London, United Kingdom
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Jean-Michel Molina
University of Paris, Paris, France
from CROI 2022 on February 16, 2022 12:00 PM-1:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 47 of 47 from CROI 2022